Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedAug 11, 2025
DataAggregated Company Financials
Companies70
- 7D-2.2%
- 3M19.6%
- 1Y25.0%
- YTD22.7%
Over the last 7 days, the Biotech industry has dropped 2.2%, driven by pullbacks in InventisBio and Sinocelltech Group of 9.0% and 6.7%, respectively. In contrast, Chengdu Kanghua Biological Products has gained 14%. Over the past 12 months, the industry was up 25%. Earnings are forecast to grow by 41% annually.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 11 Aug 2025 | CN¥965.6b | CN¥113.4b | CN¥8.3b | 41.7x | 116.4x | 8.5x |
| Wed, 09 Jul 2025 | CN¥888.1b | CN¥112.9b | CN¥8.2b | 39.4x | 107.8x | 7.9x |
| Fri, 06 Jun 2025 | CN¥903.5b | CN¥113.1b | CN¥8.2b | 35.3x | 109.6x | 8x |
| Sun, 04 May 2025 | CN¥807.0b | CN¥113.8b | CN¥7.7b | 34.3x | 105.1x | 7.1x |
| Tue, 01 Apr 2025 | CN¥841.6b | CN¥136.1b | CN¥11.7b | 31.2x | 72.2x | 6.2x |
| Thu, 27 Feb 2025 | CN¥857.3b | CN¥136.2b | CN¥10.8b | 34.6x | 79.4x | 6.3x |
| Sat, 25 Jan 2025 | CN¥798.8b | CN¥136.0b | CN¥10.8b | 32.2x | 74.3x | 5.9x |
| Mon, 23 Dec 2024 | CN¥871.6b | CN¥136.0b | CN¥10.8b | 33.9x | 81x | 6.4x |
| Wed, 20 Nov 2024 | CN¥918.1b | CN¥141.7b | CN¥11.2b | 36.6x | 82x | 6.5x |
| Fri, 18 Oct 2024 | CN¥865.7b | CN¥154.1b | CN¥14.5b | 36.6x | 59.9x | 5.6x |
| Sun, 15 Sep 2024 | CN¥737.3b | CN¥154.1b | CN¥14.5b | 30.8x | 50.8x | 4.8x |
| Tue, 13 Aug 2024 | CN¥832.0b | CN¥161.2b | CN¥17.3b | 31.2x | 48.2x | 5.2x |
| Thu, 11 Jul 2024 | CN¥808.9b | CN¥161.1b | CN¥17.3b | 30.6x | 46.8x | 5x |
| Sat, 08 Jun 2024 | CN¥877.3b | CN¥161.1b | CN¥17.3b | 31.5x | 50.7x | 5.4x |
| Mon, 06 May 2024 | CN¥950.2b | CN¥161.1b | CN¥17.3b | 34.8x | 55x | 5.9x |
| Wed, 03 Apr 2024 | CN¥977.8b | CN¥161.0b | CN¥20.1b | 39.8x | 48.6x | 6.1x |
| Fri, 01 Mar 2024 | CN¥1.0t | CN¥166.8b | CN¥22.1b | 35.9x | 45.8x | 6.1x |
| Sun, 28 Jan 2024 | CN¥964.3b | CN¥167.9b | CN¥21.4b | 35.1x | 45x | 5.7x |
| Tue, 26 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.8x | 50.6x | 6.5x |
| Thu, 23 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 41.5x | 52.1x | 6.7x |
| Sat, 21 Oct 2023 | CN¥1.0t | CN¥171.1b | CN¥25.4b | 39.1x | 40.2x | 6x |
| Mon, 18 Sep 2023 | CN¥1.0t | CN¥170.9b | CN¥25.2b | 39.5x | 41x | 6x |
| Wed, 16 Aug 2023 | CN¥1.0t | CN¥173.8b | CN¥28.2b | 38.4x | 36.9x | 6x |
| Fri, 14 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 39.7x | 36.8x | 6.1x |
| Sun, 11 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 39x | 36.9x | 6.1x |
| Tue, 09 May 2023 | CN¥1.2t | CN¥177.5b | CN¥29.5b | 42.9x | 39.9x | 6.6x |
| Thu, 06 Apr 2023 | CN¥1.2t | CN¥186.0b | CN¥36.6b | 40x | 33.7x | 6.6x |
| Sat, 04 Mar 2023 | CN¥1.3t | CN¥178.9b | CN¥36.0b | 42.9x | 35.5x | 7.1x |
| Mon, 30 Jan 2023 | CN¥1.3t | CN¥179.6b | CN¥38.0b | 44x | 35.2x | 7.4x |
| Wed, 28 Dec 2022 | CN¥1.2t | CN¥175.6b | CN¥37.9b | 38x | 31.6x | 6.8x |
| Fri, 25 Nov 2022 | CN¥1.2t | CN¥175.5b | CN¥37.9b | 39.7x | 32.8x | 7.1x |
| Sun, 23 Oct 2022 | CN¥1.2t | CN¥175.6b | CN¥41.1b | 34.7x | 29.1x | 6.8x |
| Tue, 20 Sep 2022 | CN¥1.1t | CN¥174.0b | CN¥40.1b | 30.4x | 28.2x | 6.5x |
| Thu, 18 Aug 2022 | CN¥1.3t | CN¥172.4b | CN¥43.6b | 35.7x | 28.9x | 7.3x |
Price to Earnings Ratio
28.9x
Current Industry PE
- Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 116x which is higher than its 3-year average PE of 54.2x.
- The 3-year average PS ratio of 6.4x is lower than the industry's current PS ratio of 8.5x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 42% per year over the last three years,
- Revenues have also declined 13% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 1.94% | |
| Healthcare | -0.84% | |
| Biotech | -2.20% | |
| Biotech | -2.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 300841 Chengdu Kanghua Biological Products | CN¥88.11 | 14.0% +CN¥1.4b | 68.0% | PE41.4x | |
| 300896 Imeik Technology DevelopmentLtd | CN¥187.10 | 2.1% +CN¥1.2b | 10.5% | PE30.1x | |
| 300009 Anhui Anke Biotechnology (Group) | CN¥12.30 | 4.4% +CN¥867.5m | 40.4% | PE29.4x | |
| 688192 Dizal (Jiangsu) Pharmaceutical | CN¥74.31 | 1.6% +CN¥532.9m | 92.8% | PS77.9x | |
| 000504 Landfar Bio-medicine | CN¥12.54 | 14.4% +CN¥521.4m | 80.2% | PS31.6x |